ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER evidence rating system highlighted by ISPOR task force |
|
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Good Research Practices for Retrospective Database Analysis Task Force has identified the ICER Evidence-Based Medicine (EBM) matrix as a model framework for describing judgments of comparative clinical effectiveness evidence in their Task Force Report.
|